LINC02301

Across TCGA pan-cancer cohorts, LINC02301 RNA is linked to patient survival in 15 of 34 cancer types, making it the most broadly survival-associated LINC02301 data layer.

The strongest signal is observed in lung adenocarcinoma (LUAD), where higher LINC02301 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated LINC02301 expression acts as an unfavorable survival marker, although some lineages such as ACC and BRCA show a favorable association.

LUAD, READ, and ACC are the cancer types where LINC02301 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUAD	DFS	Quartile	II,III,IV	0.532	0.723	<.001	133	view →
READ	DFS	Tertile	III,IV	0.393	0.824	.002	66	view →
ACC	OS	Tertile	IV	0.854	0.382	.008	41	view →
COAD	DFS	Tertile	II,III,IV	0.167	0.578	.014	24	view →
LGG	OS	Median	All	0.405	0.592	.009	15	view →
LIHC	OS	Tertile	All	0.676	0.799	.006	12	view →
ESCA	DFS	Median	All	0.418	0.580	.007	7	view →
BRCA	DFS	Tertile	All	0.922	0.891	.046	6	view →
PCPG	DFS	Tertile	All	0.768	0.900	.029	6	view →
THCA	OS	Tertile	III,IV	0.920	0.979	.033	5	view →
THYM	OS	Quartile	II,III,IV	0.694	1.000	.027	3	view →
SKCM	OS	Median	IV	0.621	0.140	.044	3	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 15 lineages.

LINC02301–LUAD (DFS)

Open the LUAD breakdown →